These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32964979)
1. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9. Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8893-8901. PubMed ID: 32964979 [TBL] [Abstract][Full Text] [Related]
2. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression. Wan J; Hao L; Zheng X; Li Z Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1. Wei YY; Ren TL Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression. Yu DJ; Li YH; Zhong M Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965 [TBL] [Abstract][Full Text] [Related]
6. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p. Chen AY; Zhang K; Liu GQ Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772 [TBL] [Abstract][Full Text] [Related]
7. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2. Tan T; Xu XH; Lu XH; Wang XW Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p. Jing H; Xia H; Qian M; Lv X Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells. Qiu HB; Yang K; Yu HY; Liu M Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569 [TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level. Li JZ; Li J; Liu BZ Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692 [TBL] [Abstract][Full Text] [Related]
12. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis. Hao XZ; Yang K Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127 [TBL] [Abstract][Full Text] [Related]
14. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9. Wang FF; Wang S; Xue WH; Cheng JL Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431 [TBL] [Abstract][Full Text] [Related]
16. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2. Pan MZ; Song YL; Gao F Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1. Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p. Ren XY; Han YD; Lin Q Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DANCR promoted non-small cell lung cancer cells metastasis via modulating of miR-1225-3p/ErbB2 signal. Huang YF; Zhang Y; Fu X Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):758-769. PubMed ID: 33577030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]